InsidersTradesSigma
Follow the 쎌바이오텍 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 쎌바이오텍 has logged 1 public disclosures. Market capitalisation: €101.6bn. The latest transaction was disclosed on 10 March 2026 (Other). Among the most active insiders: 쎌바이오텍. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Cell Biotech is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biotechnologies.